Evidence map›Paper›PMID 41729084›Full record

ArticleJCI insight2026

A machine learning-based triage system for systemic EBV-positive T/NK cell lymphoproliferative diseases of childhood.

Pujun Guan, Zihang Chen, Hanze Dong, Xia Guo, Juan Huang, Tian Dong, Mi Wang, Xiaoxi Lu, Fei Huang, Wenbin Li and 9 more

Abstract readMulticenter Study
In one paragraph

Article in JCI insight, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Pujun GuanDepartment of Pathology and.
Zihang ChenDepartment of Pathology and.
Hanze DongDepartment of Mathematics, The Hong Kong University of Science and Technology, Hong Kong, China.
Xia GuoDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Juan HuangDepartment of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Tian DongDepartment of Hematology and.
Mi WangDepartment of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Xiaoxi LuDepartment of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Fei HuangMOE Laboratory of Biosystem Homeostasis and Protection and Life Sciences Institute, Zhejiang University, Hangzhou, China.
Wenbin LiDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Yuan TangDepartment of Pathology and.
Li ZhangDepartment of Hematology and.
Ling PanDepartment of Hematology and.
Ju GaoDepartment of Pathology, The Affiliated Hospital of Southwest Medical University, Luzhou, China.
Shikun WangDepartment of Biostatistics, Columbia University Medical Center, New York, New York, USA.
Rongbo LiuDepartment of Radiology, West China Hospital, Sichuan University, Chengdu, China.
Wenyan ZhangDepartment of Pathology and.
Sha ZhaoDepartment of Pathology and.
Weiping LiuDepartment of Pathology and.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic Epstein-Barr virus-positive (EBV-positive) T/NK cell lymphoproliferative diseases of childhood (sEBV+T/NK-LPD) are a spectrum of rare diseases that have highly variable biological behavior, from indolent conditions to highly aggressive malignancies. Clinicians currently face substantial challenges in promptly assessing disease severity and predicting patient outcomes, leading to limitations in treatment planning. To address this challenge, we constructed a comprehensive triage system to aid in rapid clinical interventions. The study included 156 patients with newly diagnosed sEBV+T/NK-LPD from 42 institutions. An independent prospective cohort of 35 newly enrolled patients was further included to evaluate the model's performance. An additional 45 patients from the literature and 18 patients who underwent hematopoietic stem cell transplantation were included to test the score's generalizability. An integrative machine learning strategy was applied to identify robust and optimal factors and to integrate multiple algorithms to enhance the system's performance and stability. This system, termed COLLAPSED, identifies critical factors and provides a stable, high-performing ensemble. This model was validated externally and simplified into a risk score to improve interpretability and accessibility. The COLLAPSED system substantially enhances clinicians' ability to rapidly and precisely identify high-risk patients, thus enabling timely clinical decision-making and expedited initiation of potentially lifesaving treatments.

Indexed as

Epstein-Barr Virus InfectionsKiller Cells, NaturalLymphoproliferative DisordersMachine LearningTriageAdolescentChildChild, PreschoolFemaleHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanHumansInfantMalePredictive Learning ModelsProspective StudiesHematologyInfectious diseaseLymphomas

Identifiers

PMID41729084
PMCPMC12955998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.